ESA hyporesponsiveness caused various clinical conditions including bleeding/blood loss, hematopoietic disorder (infection, inflammation, and malignant tumor), deficiency of elements required for erythropoiesis (iron, folic acid, and vitamin B12 deficiency), and anti-erythropoietin antibody [28]. The gene discussed is EPO; the disease is cancer.